Diamedix Diagnostica Revenue and Competitors
Estimated Revenue & Valuation
- Diamedix Diagnostica's estimated annual revenue is currently $47.8M per year.
- Diamedix Diagnostica's estimated revenue per employee is $297,000
Employee Data
- Diamedix Diagnostica has 161 Employees.
- Diamedix Diagnostica grew their employee count by 4% last year.
Diamedix Diagnostica's People
Name | Title | Email/Phone |
---|
Diamedix Diagnostica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Diamedix Diagnostica?
Diamedix Diagnostica is a company based out of Romania.
keywords:N/AN/A
Total Funding
161
Number of Employees
$47.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diamedix Diagnostica News
2022-04-20 - STD Diagnostics Market Size, Outlook And Forecast | Abbott ...
Abbott, ADI/American Diagnostica, Agilent Technologies, ... Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX,...
2022-04-17 - Tamaño del mercado global de kits de prueba de herpes ...
Decode Genetics Diadexus Diagnocure Diagnostica Stago/Trinity Biotech Diamedix International Technidyne/Nexus DX Kreatech/Leica Polymedco
2022-04-17 - Ventas del mercado global Diagnóstico POC de atención ...
Diagnostica Stago/Trinity Biotech Diamedix ... de diagnóstico POC de atención primaria incluyen Abbott, ADI/American Diagnostica,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $29.6M | 207 | 2% | N/A |
#2 | $62.4M | 210 | 13% | N/A |
#3 | $50.9M | 230 | 5% | N/A |
#4 | $96.8M | 534 | N/A | N/A |
#5 | $333.4M | 1179 | 7% | N/A |